Axa’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-73,848
Closed -$2.74M 76
2025
Q2
$2.74M Hold
73,848
0.01% 707
2025
Q1
$2.57M Sell
73,848
-41,599
-36% -$1.39M 0.01% 689
2024
Q4
$3.74M Buy
115,447
+52,735
+84% +$1.82M 0.01% 617
2024
Q3
$2.28M Sell
62,712
-20,579
-25% -$702K 0.01% 713
2024
Q2
$2.55M Sell
83,291
-28,754
-26% -$876K 0.01% 701
2024
Q1
$3.49M Buy
112,045
+29,345
+35% +$833K 0.01% 647
2023
Q4
$2.39M Sell
82,700
-50,800
-38% -$1.42M 0.01% 700
2023
Q3
$3.64M Buy
+133,500
New +$3.71M 0.01% 597

Other funds holding ACT

Axa's ACT Position: Q3 2025 in Review

Axa sold out of Enact Holdings (ACT) in Q3 2025, closing a stake of 73,848 shares — an estimated $2.74M sold.

Axa first reported a position in ACT in Q3 2023 and held it in 8 quarters. The position peaked at $3.74M in Q4 2024. 231 funds tracked by Wall St. Rank hold ACT as of Q3 2025.

  • Axa reported no remaining Enact Holdings position as of Q3 2025 after selling out during the quarter.
  • Axa sold 73,848 Enact Holdings shares in Q3 2025, an estimated $2.74M.
  • Axa first reported a position in Enact Holdings in Q3 2023 and held it in 8 quarters.
  • Axa's Enact Holdings position peaked at $3.74M in Q4 2024.
  • 231 funds tracked by Wall St. Rank held Enact Holdings as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.